Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Related Citations for PubMed (Select 24366690)

1.

Are short telomeres hallmarks of cancer recurrence?

Shay JW.

Clin Cancer Res. 2014 Feb 15;20(4):779-81. doi: 10.1158/1078-0432.CCR-13-3198. Epub 2013 Dec 23.

2.

Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S.

Clin Cancer Res. 2014 Feb 15;20(4):904-11. doi: 10.1158/1078-0432.CCR-13-2076. Epub 2013 Nov 25.

3.

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

M'kacher R, Bennaceur-Griscelli A, Girinsky T, Koscielny S, Delhommeau F, Dossou J, Violot D, Leclercq E, Courtier MH, Béron-Gaillard N, Assaf E, Ribrag V, Bourhis J, Feneux D, Bernheim A, Parmentier C, Carde P.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):465-71. Epub 2007 Apr 6.

PMID:
17418962
4.

Radiation-associated changes in the length of telomeres in peripheral leukocytes from inpatients with cancer.

Maeda T, Nakamura K, Atsumi K, Hirakawa M, Ueda Y, Makino N.

Int J Radiat Biol. 2013 Feb;89(2):106-9. doi: 10.3109/09553002.2013.734945. Epub 2012 Oct 23.

PMID:
23020808
5.

Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.

Sugishita Y, Kammori M, Yamada O, Poon SS, Kobayashi M, Onoda N, Yamazaki K, Fukumori T, Yoshikawa K, Onose H, Ishii S, Yamada E, Yamada T.

Int J Oncol. 2013 May;42(5):1589-96. doi: 10.3892/ijo.2013.1848. Epub 2013 Mar 5.

PMID:
23467725
6.

3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".

Knecht H, Brüderlein S, Wegener S, Lichtensztejn D, Lichtensztejn Z, Lemieux B, Möller P, Mai S.

BMC Cell Biol. 2010 Dec 14;11:99. doi: 10.1186/1471-2121-11-99.

7.

Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.

Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C, Pacini F.

J Clin Endocrinol Metab. 2008 Oct;93(10):3950-7. doi: 10.1210/jc.2008-0372. Epub 2008 Jul 29.

PMID:
18664542
8.

Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease.

Strom SS, Gu Y, Sigurdson AJ, Bailey NM, Amos CI, Spitz MR, Rodriguez MA, Liang JC.

Leuk Lymphoma. 1998 Feb;28(5-6):561-6.

PMID:
9613986
9.

Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis.

Friis-Ottessen M, Bendix L, Kølvraa S, Norheim-Andersen S, De Angelis PM, Clausen OP.

BMC Gastroenterol. 2014 Jan 9;14:8. doi: 10.1186/1471-230X-14-8.

10.

Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.

Martinez-Delgado B, Gallardo M, Tanic M, Yanowsky K, Inglada-Perez L, Barroso A, Rodriguez-Pinilla M, Cañamero M, Blasco MA, Benitez J.

Breast Cancer Res Treat. 2013 Sep;141(2):231-42. doi: 10.1007/s10549-013-2696-6. Epub 2013 Sep 15.

PMID:
24036693
11.

Telomere dysfunction: a potential cancer predisposition factor.

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR.

J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8.

12.

Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Basu N, Skinner HG, Litzelman K, Vanderboom R, Baichoo E, Boardman LA.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):733-48. doi: 10.1586/17474124.2013.848790. Review.

13.

Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.

Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.

Cancer Lett. 2006 Jul 8;238(1):42-52. Epub 2005 Jul 21.

PMID:
16039041
14.

Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.

Broberg K, Björk J, Paulsson K, Höglund M, Albin M.

Carcinogenesis. 2005 Jul;26(7):1263-71. Epub 2005 Mar 3.

15.

Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.

Garaventa A, Haupt R, Panarello C, Dodero P, Gambini C, Gambaro M.

Med Pediatr Oncol. 2001 Mar;36(3):396-7. No abstract available.

PMID:
11241446
16.

Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.

Cantara S, Capuano S, Capezzone M, Benigni M, Pisu M, Marchisotta S, Pacini F.

Thyroid. 2012 Apr;22(4):363-8. doi: 10.1089/thy.2011.0109. Epub 2012 Feb 3.

PMID:
22304389
17.

Telomere shortening and survival in free-living corvids.

Salomons HM, Mulder GA, van de Zande L, Haussmann MF, Linskens MH, Verhulst S.

Proc Biol Sci. 2009 Sep 7;276(1670):3157-65. doi: 10.1098/rspb.2009.0517. Epub 2009 Jun 11.

18.

Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q.

PLoS One. 2011;6(6):e20466. doi: 10.1371/journal.pone.0020466. Epub 2011 Jun 10.

19.

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J.

Cancer. 2013 Dec 15;119(24):4277-83. doi: 10.1002/cncr.28367. Epub 2013 Sep 16.

20.

Telomere length influences cancer cell differentiation in vivo.

Hirashima K, Migita T, Sato S, Muramatsu Y, Ishikawa Y, Seimiya H.

Mol Cell Biol. 2013 Aug;33(15):2988-95. doi: 10.1128/MCB.00136-13. Epub 2013 May 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk